PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Hsu, Joanne I., Dayaram, Tajhal, Tovy, Ayala, De Braekeleer, Etienne, Jeong, Mira, Wang, Feng, Zhang, Jianhua, Heffernan, Timothy P. +12 more·2018·Cell stem cell

DOI 10.1016/j.stem.2018.10.004

Cited by (426)

Items 301–400 of 426

How predictive is the finding of clonal hematopoiesis for the development of myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML)?
David P. Steensma · 2021 · Best Practice & Research Clinical Haematology
The etiology of clonal mosaicism in human aging and disease
Sanne Massaar, Mathijs Arnoud Sanders · 2023 · Aging and Cancer
PPM1D activity promotes the replication stress caused by cyclin E1 overexpression
Andra S. Martinikova, Miroslav Stoyanov, Anna Oravetzova, Yannick P. Kok, Shibo Yu, Jana Dobrovolná, Pavel Janščák, Marcel A.T.M. van Vugt, Libor Macůrek · 2023 · Molecular Oncology
Employing the CRISPR-Cas System for Clonal Hematopoiesis Research.
Hayato Ogawa, Soichi Sano, Kenneth Walsh · 2021 · PubMed
In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns
Shu‐Hong Lin, Youjin Wang, Stephen W. Hartley, Danielle M. Karyadi, Olivia W. Lee, Bin Zhu, Weiyin Zhou, Derek W. Brown, Erin E. Beilstein-Wedel, Rohan Hazra et al. · 2021 · AIDS
Chemotherapy Signatures Map Evolution of Therapy-Related Myeloid Neoplasms
Benjamin T. Diamond, Bachisio Ziccheddu, Kylee H. Maclachlan, Justin Taylor, Eileen Mary Boyle, Juan Arango Ossa, Jacob Jahn, Maurizio Affer, Tulasigeri M. Totiger, David Glen Coffey et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin.
D. Karpova, H. Encabo, E. Donato, I. Kotova, S. Calderazzo, A. Leppae, J. Panten, A. Przybylla, E. Seifried, A. Kopp-Schneider et al. · 2022 · medRxiv
Mechanisms of Germline Stem Cell Competition across Species
Rachel A. Hodge, Erika A Bach · 2024 · Life
Impact of Clonal Hematopoiesis on Solid Tumor Progression Following Radiation Therapy
Jacqueline J. Tao, Jeremy S. Setton, Pablo Sánchez Vela, Anton Mikhailovich Safonov, Elizabeth Anne Comen, Lior Zvi Braunstein, Jorge Sergio Reis-Filho, Nadeem Riaz, Simon N. Powell, Ross L. Levine et al. · 2025 · JCO Precision Oncology
Progress in the Genetics of Myelodysplastic Syndromes with a Latin American Perspective
Ana Lisa Basquiera, Verónica Andreoli, Sofía Grille, Carolina Belli · 2025 · Genes
Association of high‐dose radioactive iodine therapy with PPM1D ‐mutated clonal hematopoiesis in older individuals
Jaeryuk Kim, Sungwoo Bae, Jaeyong Choi, Sun-Wha Im, Bukyoung Cha, Gyeongseo Jung, Sun Wook Cho, Eul‐Ju Seo, Young Ah Lee, Jin Chul Paeng et al. · 2025 · Molecular Oncology
Clonal hematopoiesis in AML long‐term survivors: Risk factors and clinical consequences
Simon M. Krauß, Eva Telzerow, Daniel Richter, Anna Sophia Moret, Maja Rothenberg‐Thurley, Cristina Sauerland, Anne Weigert, Alessia Fraccaroli, Johanna Tischer, Frank Ziemann et al. · 2025 · HemaSphere
The interplay of clonal hematopoiesis and cancer: Clinical implications in oncology
Mégane Tanguay, Marco Tagliamento, Juliette Samaniego, Benjamin Besse, Aline Renneville, E. Bernard, Jean‐Baptiste Micol · 2026 · Cancer Treatment Reviews
Murine Modeling of Myeloproliferative Neoplasms
Karie Chen, Alan H. Shih · 2020 · Hematology/Oncology Clinics of North America
What Clonal Hematopoiesis Can Teach Us About MDS
Irenaeus C.C. Chan, Brian J. Wiley, Kelly L. Bolton · 2022 · Frontiers in Oncology
Factors associated with clonal hematopoiesis and interaction with marrow environment
Yasuhito Nannya · 2022 · Journal of Bone and Mineral Metabolism
Multiplex gene editing models of del(7q) reveal combined CUX1 and EZH2 loss drives clonal expansion and drug resistance
Matthew R. M. Jotte, Angela Stoddart, Tanner C. Martinez, Raven Moten, Yuqing Xue, Molly K. Imgruet, Hunter Z. Blaylock, Henna S. Nam, Bonnie Y. Hu, Jermaine Austin et al. · 2025 · Blood Neoplasia
Development of myeloid neoplasia associated with prolonged immune cell‐associated hematotoxicity after CAR T‐cell treatment of B‐cell lymphoma: Should we surveille for pre‐existing myeloid mutations?
Mattias Carlsten, Elisa Linnea Lindfors Rossi, Martin Jädersten, Bianca Tesi, Sulaf Abd Own, Birgitta Sander, Stefan Deneberg, Anne Ivinskiy, Kristina Sonnevi, Hanna Sjölund et al. · 2025 · HemaSphere
Genomic profile helps to predict the clonal evolution and outcome of BCR-ABL-negative myeloproliferative neoplasms
Xiaodong Guo, Wenbo Jia, Xinyu Yang, Hexiao Jia, Hanyang Wu, Yihong Wei, Can Can, Na He, Hailei Zhang, Wancheng Liu et al. · 2025 · Translational Oncology
Klonale Hämatopoese – Teil 1
Detlef Thomas Haase · 2019 · best practice onkologie
Potential Pre‐Leukemic Mutations in PPM1D Confer Chemotherapy Resistance to Aged HSC Clones
Michael D. Milsom · 2019 · HemaSphere
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Etienne D. Braekeleer, Chun-Wei Chen, Tajhal D. Patel, Alejandra G. Martell, Anna G. Guzman, Katharina Wohlan, Sarah M. Waldvogel, Hidetaka Urya et al. · 2023 · eLife
An ATM-PPM1D Circuit Controls the Processing and Restart of DNA Replication Forks
Yiting Cao, Yingzheng Wang, Jumana Badar, Khoula Jaber, Vitor Marcel Faça, Tyler C. Huang, Eliz Çelik, Marcus Bustamante Smolka · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Aging, Causes, and Rejuvenation of Hematopoietic Stem Cells
Zhiyang Chen, Zhenyu Ju, Yan Sun · 2023 · Advances in experimental medicine and biology
Myelodysplastic syndromes among atomic bomb survivors in Nagasaki: similarities to and differences from de novo and therapy-related cases
Koji Ando, Yasushi Miyazaki · 2024 · Journal of Radiation Research
Identification of small molecule inhibitors of PPM1D using an integrated drug discovery platform
Subrata Shaw, Wei Jiang, Jason S. Rush, Nancy Dumont, John Kim, Ritu Singh, Adam P. Skepner, Carol Khodier, Cerise Raffier, Zachary Murphy et al. · 2025 · iScience
PPM1D Mutation as a Distinct Feature of Myeloid Neoplasms in B-Cell Non-Hodgkin Lymphoma Patients: A Retrospective Analysis
Heyjin Kim, Jin Kyung Lee, Young Jun Hong, Hye Jin Kang, Byung Hyun Byun, Seung‐Sook Lee · 2025 · Cancers
Spectrum, Prevalence, and Clinical Correlates of PPM1D Mutations in Patients with Clonal Haematopoiesis and Clonal Cytopenias
Talha Badar, Ludovica Marando, Terra Lasho, Francyess Denis Oliva, Chenyu Lin, Benjamin J. McCormick, Mobachir El Kettani, Kashish J. Shah, Yael N. Kusne, OMER HASSAN JAMY et al. · 2025 · EMJ Hematology
The Impact of Dose, Sex, and Age at Time of Acute Whole-body Radiation Exposure on Long-term Hematopoiesis in Rhesus Macaques (Macaca mulatta)
Yuiko Chino, John D. Olson, Stephen Aichele, Susan M. Bailey, George William Schaaf, J. Mark Cline, Thomas E. Johnson · 2025 · Radiation Research
Clonal hematopoiesis in patients with cancer and cancer survivors: From clonal burden to cardiovascular diseases
Christian H. Nenninger, Keith Anderson, Jenaro Espitia-Corredor, Brittany Echevarria, Vertica Agnihotri, Zhao Wang, Scott R. Goldsmith, June‐Wha Rhee · 2026 · Cancer
Ppm1d Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models
Cesar De Jeronimo Diaz, Huajun Liao, Brian Hardaway, Linke Li, Anna Lu Gan, Mandy Liu, Alice Kim, Grace Qian, Sandra Abramowicz, Edithe Lam et al. · 2026 · Arteriosclerosis Thrombosis and Vascular Biology
Combined inhibition of PLK4 and PPM1D promotes cell death in cancer cells with 17q amplification
Miroslav Stoyanov, Cecilia Aquino-Perez, Shreyasi Mazumder, Dominika Salcakova, Silvia Petrezsélyová, Libor Macůrek · 2026 · Cancer Cell International
Germ line landscape stratification defines distinct molecular and prognostic groups in therapy-related myeloid neoplasms
Oriol Calvete, Julia Mestre, Lorea Chaparro‐González, Lucía Ruiz Perez-Hita, Alba Mesa Tudel, Blanca Xicoy, Lurdes Zamora, Isabel Granada, Mar Mallo, Emili Cid et al. · 2026 · Blood Advances
Under pressure: clonal hematopoiesis in patients receiving cancer therapy
Vincent Rondeau, Elina K. Cook, Robert J. Vanner · 2026 · Trends in cancer
Cancer treatment alters mutant selection in normal esophagus
Joanna C. Fowler, Giuseppina Arbore, Roshan K. Sood, Irina Abnizova, Luca Albarello, Oliver J. Pickering, Kasumi Murai, Ujjwal Banerjee, Salomé Brunon, Swee Hoe Ong et al. · 2026 · Nature Genetics
Germline homologous recombination deficiency influences TP53-mutant clonal hematopoiesis fitness during platinum and PARP inhibitor treatment
Jeremy T. Baeten, Irenaeus C.C. Chan, Lea A. Moukarzel, Giulia E.M. Petrone, Jie Liu, Duc Tran, Jacob Tabs, Imène Tabet, Sumedha Agashe, Elaheh Nasrollahzadeh et al. · 2026 · Nature Genetics
Wild-type p53-induced phosphatase sensitizes acute myeloid leukemia cells to conventional chemotherapy
Vasily Golotin, Ekaterina Belotserkovskaya, Larisa Girshova, Alexey Petukhov, Andrey Zaritsky, Oleg N. Demidov · 2021 · Biological Communications
Genome-Based Medicine for Acute Myeloid Leukemia: Study and Targeting of Molecular Alterations and Use of Minimal Residual Disease as a Biomarker
Ugo Testa, Germana Castelli, Elvira Pelosi · 2022 · Hemato
Klonale Hämatopoese – Ursachen und klinische Implikationen
Andreas Burchert · 2023 · Zeitschrift für Gerontologie und Geriatrie
Double Malignancy and Double Transplant—A Bumpy Road to Success
Michał Razik, Patrycja Rozwadowska, Anna Koclęga, Grzegorz Helbig · 2023 · Medicina
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, Geun‐Ho Park, Yeon Jeong Kim, Woong‐Yang Park, Se‐Hoon Lee, Murim Choi · 2024 · eLife
Precursor Hematologic Conditions: Diagnosis, Risk Stratification, Clinical Implications, and Management
Yuxin Liu, Pinkal M. Desai, Omar Nadeem, Jennifer Ann Woyach, Aseel Alsouqi · 2025 · American Society of Clinical Oncology Educational Book
Therapy-related acute myeloid leukemia and its prevention.
Gennady A. Belitsky, Timur I. Fetisov, Кирсанов Кирилл Игоревич, Ekaterina A. Lesovaya, Olga Vlasova, Якубовская Марианна Геннадиевна · 2020 · Europe PMC (PubMed Central)
Bedeutung der klonalen Hämatopoese für hämatologische Neoplasien
Katharina S. S. Götze, Claudia Lengerke · 2022 · Die Innere Medizin
Klonale Hämatopoese und solide Neoplasien
Christopher Maximilian Arends, Frédérik Damm · 2022 · Die Innere Medizin
Einfluss der klonalen Hämatopoese auf nicht-hämatologische Erkrankungen und Alterungsprozesse
Michael A. Rieger · 2022 · Die Innere Medizin
Untangling the Relationship Between Clonal Hematopoiesis and Ovarian Cancer Therapies
Koichi Takahashi · 2021 · JNCI Journal of the National Cancer Institute
The Journey to Clonal Hematopoiesis and Applications Incardiovascular Disease and Cancer
Santiago Redondo, Jaime Pérez de Oteyza · 2023 · Preprints.org
PPM1D inhibition may allow us to WIP leukemia
Bridget Kelly Marcellino · 2023 · Blood
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, Geun‐Ho Park, Yeon Jeong Kim, Woong‐Yang Park, Se‐Hoon Lee, Murim Choi · 2024 · eLife
Risk of Clonal Hematopoiesis of Indeterminate Potential after Cancer Radiation Therapy
Shelby Crants, Sydney S. Olson, Yajing Li, Cosmin Adrian Bejan, Caitlyn Vlasschaert, Taralynn M. Mack, Yash Pershad, Ashwin Kishtagari, Sarah C. Reed, Sarah Croessmann et al. · 2024 · medRxiv
Clinical Features and Prognostic Nomogram for Therapy-Related Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation
Menglin Li, Yimeng Li, Qingyuan Qu, Chen‐Cong Wang, Qi Chen, Xiaolu Zhu, Yun He, Yuanyuan Zhang, Hao Jiang, Qian Jiang et al. · 2024 · SSRN Electronic Journal
Klonale Hämatopoese – Teil 2
Detlef Thomas Haase · 2019 · best practice onkologie
Sensitivity of Cells with Various Levels of Ppm1d Expression to Classical Chemotherapeutic Drugs for Colorectal Cancer Treatment
Elena Y. Kochetkova, Bogdan B. Grigorash, Oleg N. Demidov · 2019 · Cell and Tissue Biology
Molecular Landscape of MDS
Torsten Haferlach, Ines Schmidts · 2020 · Springer eBooks
Role of clonal gemopoeisis in development of individual approaches for early diagnostics, treatment and rehabilitation of patients with cardio-vascular diseases
Oleg N. Demidov, Alexander V. Shakula, Г В Гулеватый, A.V. Sobolev · 2020 · Bulletin of Rehabilitation Medicine
Precision Medicine in Clonal Hematopoiesis: New Data on Risk for Transformation
Adam J. Mead, Jennifer O'Sullivan · 2020 · The Hematologist
A view from the hospital window.
Albert G. Richards · 1974 · PubMed Central
Hematopoyesis Clonal de Potencial Indeterminado (HCPI): más allá de un modelo de campo de cancerización
Oscar Andrés Franco, Natalia Olaya Morales · 2021 · Revista Colombiana de Cancerología
Relationship between leukaemic stem cells and hematopoietic stem cells and their clinical application
Samuel Sherng Young Wang · 2022 · Leukemia & lymphoma/Leukemia and lymphoma
Pathogenese und molekulare Diagnostik der akuten myeloischen Leukämie
Alwin Krämer, Christian Thiede · 2022 · Die Onkologie
Klonale Hämatopoese – Ursachen und klinische Implikationen
Andreas Burchert · 2022 · Die Innere Medizin
Clonal Hematopoiesis in Cancer
Philipp J. Rauch, David P. Steensma · 2022 · Holland‐Frei Cancer Medicine
Klonale Hämatopoese und solide Neoplasien
Christopher Maximilian Arends, Frédérik Damm · 2023 · Wiener klinisches Magazin
Genetische Varianten von PPM1D und TP53 bei Patienten mit myelodysplastischen Syndromen und komplex-aberranten Karyotypen
Lea Naomi Eder · 2023
Data from Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia
Barbara G. Spitzer, Kayleigh D. Rutherford, Gunes Gundem, Erin M. McGovern, Nathan E. Millard, Juan Arango Ossa, Irene Y. Cheung, Teng Gao, Max Fine Levine, Yanming Zhang et al. · 2023
EXABS-171-MDS Update on CHIP and CCUS
Lachelle Dawn Weeks · 2023 · Clinical Lymphoma Myeloma & Leukemia
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Etienne D. Braekeleer, Chun-Wei Chen, Tajhal D. Patel, Hidetaka Urya, Anna G. Guzman, Alejandra G. Martell, Sarah M. Waldvogel, Ayala Tovy et al. · 2023 · eLife
Cardio-oncology: new insights into association and interaction between cardiovascular disease and cancer
Canxia Shi · 2023
Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis
Santiago Demajo, Joan E. Ramis-Zaldivar, Ferran Muiños, Miguel L. Grau, Maria A. Andrianova, Núria López-Bigas, Abel González-Pérez · 2023 · medRxiv
The Origin of Clonal Hematopoiesis and Its Implication in Human Diseases
Zhen Zhang, Jianlong Sun · 2023 · Advances in experimental medicine and biology
SOD1 is a synthetic lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Etienne D. Braekeleer, Chun-Wei Chen, Tajhal D. Patel, Alejandra G. Martell, Anna G. Guzman, Katharina Wohlan, Sarah M. Waldvogel, Hidetaka Urya et al. · 2024 · eLife
Additional file 2 of Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Md Mesbah Uddin, Ying Zhou, Alexander G. Bick, Bala Bharathi Burugula, Siddhartha Jaiswal, Pinkal M. Desai, Michael C. Honigberg, Shelly-Ann M. Love, Ana Barac, Kathleen M. Hayden et al. · 2022 · Figshare
Identification of Small Molecule Inhibitors of PPM1D Using a Novel Drug Discovery Platform
Wei Jiang, Subrata Shaw, Jason S. Rush, Nancy Dumont, John Kim, Ritu Singh, Adam P. Skepner, Carol Khodier, Cerise Raffier, Ni Yan et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
SOD1 is a synthetic-lethal target in PPM1D-mutant leukemia cells
Linda Zhang, Joanne I. Hsu, Etienne D. Braekeleer, Chun-Wei Chen, Tajhal D. Patel, Alejandra G. Martell, Anna G. Guzman, Katharina Wohlan, Sarah M. Waldvogel, Hidetaka Uryu et al. · 2024 · eLife
Reviewer #1 (Public Review): Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, Geun-Ho Park · 2024 · eLife
eLife Assessment: Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Claire N. Harrison · 2024 · eLife
Reviewer #2 (Public Review): Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, Geun-Ho Park · 2024 · eLife
The Clonal Hematopoiesis-associated Gene Srcap Plays an Essential Role in Hematopoiesis
Terrence Wong, Anna Mychalowych, Ellie R. Feldpausch, Alexander Carson, Darja Karpova, Daniel C. Link · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
THE ROLE OF CELLULAR PLASTICITY OF VASCULAR WALL CELLS AND HEMATOPOIETIC SYSTEM IN ATHEROGENESIS
А. А. Слепцов · 2024 · Complex Issues of Cardiovascular Diseases
Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden
Hyungtai Sim, Hyun Jung Park, Geun‐Ho Park, Yeon Jeong Kim, Woong‐Yang Park, Se‐Hoon Lee, Murim Choi · 2024 · eLife
Secondary haematological dysplasia after CAR ‐T‐cell therapy for acute lymphoblastic leukaemia in children
Alexandre Théron, Anna Alonso‐Saladrigues, José Luís Dapena, Monica López‐Duarte, Cristina Díaz de Heredia, Jaime Verdú‐Amorós, Edurne Sarrate, Elena Esperanza‐Cebollada, Esther Cuatrecasas, Sandra Andreu et al. · 2024 · British Journal of Haematology
ВЛИЯНИЕ КЛОНАЛЬНОГО ГЕМАТОПОЭЗА С НЕОПРЕДЕЛЕННЫМ ПОТЕНЦИАЛОМ (CHIP) НА РАЗВИТИЕ АТЕРОСКЛЕРОЗА
Makhabbat S. Bekbossynova, S.A. Andosova, A. Rysbekova, Daniyarova Gulnur D. · 2024 · Ġylym men densaulyķ saķtau.
Low-Frequency PPM1D Gene Mutations Associated with Inferior Treatment Response to CD19 Targeted CAR-T Cell Therapy in Mantle Cell Lymphoma
Katja Seipel, Lynn Benninger, Ulrike Bacher, Thomas Pabst · 2024 · Therapeutics
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and chronic myeloid leukemia
Violaine Tran Quang, Jules Cretin, Romain Loyaux, Bilel Ben Jedidia, Sihem Tarfi, Guillaume Gricourt, Quentin Barathon, Corine Joy, Pascaline Etancelin, Orianne Wagner‐Ballon et al. · 2025 · Annals of Hematology
Myeloproliferative neoplasms: A model of the journey from clonal hematopoiesis to cardiovascular disease and cancer
Santiago Redondo · 2025 · Clínica e Investigación en Arteriosclerosis
Commentary on “Arterial thromboembolic events in testicular cancer patients: short- and long-term incidence, risk factors, and impact on mortality”
Hege Sagstuen Haugnes, Torgrim Tandstad · 2025 · Journal of Thrombosis and Haemostasis
Diffusely Increased Bone Marrow Uptake on DOTATATE PET/CT Due to PRRT-related Myelodysplasia Syndrome
Chenxi Wu, Ekaterina Menshikova, Amol Madan Takalkar · 2025 · Clinical Nuclear Medicine
A case of ADH5/ALDH2 deficiency combined with 3q29 microduplication syndrome
Shu Chenzhuo, Fu Lingling, Wei Ang, Chen Hui, Ruixin Wang, Yang Bixi, Li Hongmin, Jie Ma, Tianyou Wang · 2025 · BMC Pediatrics
Impaired IL-10 Receptor Signaling Leads to Inflammation Induced Exhaustion in Hematopoietic Stem Cells
William Lucas P Wadley, Helen Q. Huang, Hew Yeng Lai, Jianhong C Heidmann, Jane Chen, Eli M. Soyfer, Kalei Guillermo, Eshika Arora, Lauren Chen, Brianna Hoover et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
Myeloproliferative neoplasms: A model of the journey from clonal hematopoiesis to cardiovascular disease and cancer
Santiago Redondo · 2025 · Clínica e Investigación en Arteriosclerosis (English Edition)
Additional file 1 of Longitudinal profiling of clonal hematopoiesis provides insight into clonal dynamics
Md Mesbah Uddin, Zhou, Ying, Alexander G. Bick, Burugula, Bala Bharathi, Siddhartha Jaiswal, Desai, Pinkal, Michael C. Honigberg, Love, Shelly-Ann, Barac, Ana, Hayden, Kathleen M. et al. · 2022 · Figshare
Additional file 2 of Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, Jiwon, Hyojin Song, Kim, Sung-Min, Kim, Soonok, Seok Ryun Kwon, Lee, Young Eun, Jeong, Dajeong, Park, Jae Hyeon, Kwon, Sunghoon, Yun, Hongseok et al. · 2024 · Figshare
Additional file 1 of Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, Jiwon, Hyojin Song, Kim, Sung-Min, Kim, Soonok, Seok Ryun Kwon, Lee, Young Eun, Jeong, Dajeong, Park, Jae Hyeon, Kwon, Sunghoon, Yun, Hongseok et al. · 2024 · Figshare
Additional file 5 of Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, Jiwon, Hyojin Song, Kim, Sung-Min, Kim, Soonok, Seok Ryun Kwon, Lee, Young Eun, Dajeong Jeong, Park, Jae Hyeon, Kwon, Sunghoon, Yun, Hongseok et al. · 2024 · Figshare
Additional file 3 of Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, Jiwon, Hyojin Song, Kim, Sung-Min, Kim, Soonok, Seok Ryun Kwon, Lee, Young Eun, Jeong, Dajeong, Park, Jae Hyeon, Kwon, Sunghoon, Yun, Hongseok et al. · 2024 · Figshare
Additional file 4 of Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
Yun, Jiwon, Hyojin Song, Kim, Sung-Min, Kim, Soonok, Seok Ryun Kwon, Lee, Young Eun, Jeong, Dajeong, Park, Jae Hyeon, Kwon, Sunghoon, Yun, Hongseok et al. · 2024 · Figshare
In vivo isogenic modelling unveils TP53 -associated relapse trajectories in T-cell acute lymphoblastic leukemia
Stéphanie Gachet, Samuel Quentin, Lucie Hernandez, Loïc Maillard, Marie Passet, Rathana Kim, Hugo Bergugnat, Melha Benlebna, Remy Jelin, Marine Aglave et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
Drug and Toxin Effects on Bone Marrow
2026 · American Registry of PathologyArlington, Virginia eBooks
Clonal Nonmalignant Conditions
2026 · American Registry of PathologyArlington, Virginia eBooks